Wang and colleagues found that in human estrogen receptor positive breast cancer cells, estrogen promotes a CSC and EMT phenotype via activation of Gli1, a downstream effector of the Hh pathway (Sun et al., 2014). Here, GLI1 is linked to breast cancer.